Evidence map›Paper›PMID 39673305›Full record

ArticleNucleic acids research2024

Distinct interactomes of ADAR1 nuclear and cytoplasmic protein isoforms and their responses to interferon induction.

Dragana Vukić, Anna Cherian, Salla Keskitalo, Yih Tyng Bong, Martin Marônek, Leena Yadav, Liam P Keegan, Markku Varjosalo, Mary A O'Connell

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Global analysis by LC-MS/MS ofRNA (New York, N.Y.) · 2025
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dragana VukićCentral European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, Brno 62500, Czechia.
Anna CherianCentral European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, Brno 62500, Czechia.
Salla KeskitaloInstitute of Biotechnology, HelsinkiInstitute of Life Science (HiLIFE), University of Helsinki, Helsinki 00014, Finland.
Yih Tyng BongInstitute of Biotechnology, HelsinkiInstitute of Life Science (HiLIFE), University of Helsinki, Helsinki 00014, Finland.
Martin MarônekCentral European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, Brno 62500, Czechia.
Leena YadavInstitute of Biotechnology, HelsinkiInstitute of Life Science (HiLIFE), University of Helsinki, Helsinki 00014, Finland.
Liam P KeeganCentral European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, Brno 62500, Czechia.ORCID 0000-0001-7915-5790
Markku VarjosaloInstitute of Biotechnology, HelsinkiInstitute of Life Science (HiLIFE), University of Helsinki, Helsinki 00014, Finland.ORCID 0000-0002-1340-9732
Mary A O'ConnellCentral European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, Brno 62500, Czechia.ORCID 0000-0003-3844-6174

Funding

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
GAČR 21-27329XGAČR by 22-26278KGrantová agentura České republiky GAČR 20-11101SNIGMS NIH HHS R01 GM129325
6 · The paper itself

Abstract

The RNA editing enzyme adenosine deaminase acting on RNA 1 (ADAR1) is essential for correct functioning of innate immune responses. The ADAR1p110 isoform is mainly nuclear and ADAR1p150, which is interferon (IFN) inducible, is predominately cytoplasmic. Using three different methods - co-immunoprecipitation (co-IP) of endogenous ADAR1, Strep-tag co-IP and BioID with individual ADAR1 isoforms - a comprehensive interactome was generated during both homeostasis and the IFN response. Both known and novel interactors as well as editing regulators were identified. Nuclear proteins were detected as stable interactors with both ADAR1 isoforms. In contrast, BioID identified distinct protein networks for each ADAR1 isoform, with nuclear components observed with ADAR1p110 and components of cytoplasmic cellular condensates with ADAR1p150. RNase A digestion distinguished between distal and proximal interactors, as did a double-stranded RNA (dsRNA)-binding mutant of ADAR1 which demonstrated the importance of dsRNA binding for ADAR1 interactions. IFN treatment did not affect the core ADAR1 interactomes but resulted in novel interactions, the majority of which are proximal interactions retained after RNase A treatment. Short treatment with high molecular weight poly(I:C) during the IFN response resulted in dsRNA-binding-dependent changes in the proximal protein network of ADAR1p110 and association of the ADAR1p150 proximal protein network with some components of antiviral stress granules.

Indexed as

Adenosine DeaminaseCell NucleusCytoplasmProtein IsoformsRNA-Binding ProteinsHEK293 CellsHeLa CellsHumansInterferonsPoly I-CProtein BindingProtein Interaction MapsRNA, Double-StrandedRNA EditingADAR protein, humanAdenosine DeaminaseInterferonsPoly I-CProtein IsoformsRNA-Binding ProteinsRNA, Double-Stranded

Identifiers

PMID39673305
PMCPMC11662693

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.